Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    10984562 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Multi-Institutional Phase II Feasibility Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
Conditions: Neuroepithelial Tumor;   Solid Tumor;   Allogeneic Hematopoietic Stem Cell Transplantation
Interventions: Procedure: Allogeneic hematopoietic stem cell transplant following thiotepa-based marrow ablative chemotherapy;   Drug: Keratinocyte Growth Factor;   Drug: Alemtuzumab;   Drug: Thiotepa;   Drug: Etoposide;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Tacrolimus;   Drug: Cyclosporine A;   Drug: Mycophenolate mofetil
2 Unknown  Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil

Indicates status has not been verified in more than two years